Opinion | Drug Companies Will Make a Killing From Coronavirus – The New York Times – By Mariana Mazzucato and Azzi Momenghalibaf – March 18, 2020
Unless we fix the system, American taxpayers will get gouged on a vaccine they paid to produce.
The search for treatments and vaccines to curb transmission of the new coronavirus is in overdrive. Fortunately, there are a number of promising candidates thanks to the U.S. government’s investment in biomedical research and development.
As the world’s leader in public financing of biomedical research, the U.S. government has the opportunity to set a precedent to ensure that medicines developed with public funding are accessible and affordable to the public; this will have enormous implications not only how for we deal with the coronavirus, but also for the crisis of unaffordable medicines in America. Continue reading